Abstract
Background
The treatment of bacterial infections remains a challenging therapeutic problem because of emerging infectious diseases as well the increasing number of multidrug resistant microbial pathogens. Despite the many antimicrobial and chemotherapeutic agents are available in market, the emergence of old and new antibiotic resistant bacterial species in the last decade lead to a substantial need for the discovery of new classes of antimicrobial compounds [1] . Cancer is one of the most serious health problems all over the world and one of the leading causes of death. Thus, in the past for several decades, researchers have been struggling to find effective clinical approaches for the treatment of cancer and search for novel anticancer agents [2] . Among a wide variety of heterocyclic compounds that have been explored for developing medicinally important molecules, nitrogen containing heterocyclic pyrimidine derivatives occupies an important place in the field of medicinal chemistry [3] . The presence of a pyrimidine base in thymine, cytosine and uracil, which are the essential binding blocks of nucleic acids, DNA and RNA is one possible reason for their biological and therapeutical activities. Number of marketed drugs ( Fig. 1) contains pyrimidine nucleus i.e. nilotinib (i) and capecitabine (ii) as anticancer; proquazone (iii) as anti-inflammatory; idoxuridine (iv) and trifluoridine (v) Open Access *Correspondence: naru2000us@yahoo.com 1 Faculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak 124001, India Full list of author information is available at the end of the article as antiviral; zidovudine (vi) and stavudine (vii) as anti-HIV; trimethoprim (viii) and sulphamethiazine (ix) as antibacterial; pyrimethamine (x) as antimalarial; minoxidil (xi) and ketanserin (xii) as antihypertensive [4] . The literature survey indicated that a wide range of pharmacological activities are exhibited by the compounds encompassing pyrimidine nucleus i.e. antibacterial [5] , antifungal [6] , antileishmanial [7] , antimycobacterial [8] , antimicrobial [9] , anti-inflammatory [10] , anticancer [11] , antiviral [12] , antitubercular [13] , antimalarial [14] , antioxidant activity [15] , central nervous system (CNS) depressant and calcium channel blocker [8] . Based on the literature survey and biological profile of bis-pyrimidine acetamides summarized in Fig. 2 and in continuation of our efforts in searching novel antimicrobial and anticancer agents [16] [17] [18] , in the present work, we hereby report the synthesis, antimicrobial and anticancer activities of a series of bis-pyrimidine acetamide derivatives.
Results and discussion

Chemistry
A general approach to synthesize the designed bispyrimidine acetamide derivatives based on ClaisenSchmidt condensation is outlined in Scheme 1. Initially, the bis-chalcone (I) was synthesized by the reaction of 1-(4-nitrophenyl)ethanone and terephthalaldehyde. The cyclization of a bis-chalcone into the corresponding bis-pyrimidine (II) was accomplished by the reaction of the bis-chalcone with guanidine nitrate. The reaction of bis-pyrimidine (II) with 2-chloroacetyl chloride resulted in the formation of III {N,N′-(6,6′-(1,4-phenylene) bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-chloroacetamide)} which on reaction with corresponding substituted aniline yielded the title compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . The chemical structures of the synthesized compounds were established by the determination of their physicochemical and spectroscopic data (FT-IR, 1 H-NMR, 13 C-NMR, Mass) and elemental analyses. The structure of the bis-chalcone was confirmed by the corresponding IR (KBr pellets, cm −1 ). The IR spectrum of bis-chalcone (I) showed the characteristic band at 1690 cm −1 which indicated the presence of a -C=O group and characteristic bands at 3106 and 1517 cm −1 indicated the presence of C-H and C=C group in aromatic ring respectively. The existence of Ar-NO 2 group in bis-chalcone (I) was displayed by the existence of symmetric Ar-NO 2 stretches in the scale of 1341 cm −1 and characteristic bands at 2906 and 1598 cm −1 indicated the presence of C-H and C=C group in alkyl chain respectively. Bis-pyrimidine (II) showed the characteristic bands at 3106 and 1518 cm −1 for the presence of C-H and C=C group in aromatic ring respectively and characteristic bands at 3370, 1600 and 1349 cm −1 for indicated the presence of C-NH 2 ; N=CH str., of pyrimidine and C-N sym stretches of Ar-NO 2 group. N,N′- (6, bis (4-(4- nitrophenyl)pyrimidine-6,2-diyl))bis(2-chloroacetamide) III showed appearance of IR stretching around 3105 and 1519 cm −1 in the spectral data for the presence of C-H and C=C group in aromatic ring respectively and characteristic bands at 1688, 1599, 2928, 761 and 1349 cm −1
Fig. 1 Some marketed drugs contains pyrimidine moiety
for the NH-C=O; N=CH str., of pyrimidine; C-H str., CH 2 ; C-Cl str., (Ar-Cl); C-N sym str. of aromatic NO 2 group respectively. The structure of the bis-chalcone and its cyclized products were further confirmed by the corresponding 1 H-NMR spectra. The 1 H-NMR spectrum of bis-chalcone I showed two doublets at 7.59 ppm (J = 15.1 Hz) and 8.06 ppm (J = 15.1 Hz); indicating that the CH=CH group in the enone linkage is in a transconformation. The H-NMR spectrum of compound intermediate-II showed a sharp singlet at 6.99 δ, ppm due to the NH 2 protons and it also showed a sharp singlet at 7.86 δ, ppm due to HC=C group, which confirmed the cyclization of the bis-chalcone into a bispyrimidine ring. Intermediate (III) showed the multiplet signals between 7.54 and 8.93 δ, ppm in 1 H-NMR spectra which is indicative of aromatic proton and also exhibited sharp singlet at 7.42, 8.10, 3.66 δ, ppm due to the presence of HC=C; -NH; -CH 2 respectively confirmed the conversion of the bis-pyrimidine into bis-pyrimidine acetamide. The appearance of IR stretching around 1575-1569, 3086-2851 and 1580-1600 cm −1 in the spectral data of synthesized derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) specified the existence of C=N group of pyrimidine ring; C-H and C=C group respectively. The IR absorption band in the scale of 1106-1105 cm −1 corresponds to the C-F stretching of aromatic-fluoro compounds (11 and 12) and 697-536 cm −1 corresponds to the C-Br stretching of aromatic-bromo derivative (16) . The existence of an arylalkyl ether category (C-O-C, Ar-OCH 3 ) in derivatives, 4, 19 and 20 are established by the existence of an IR symmetric stretches around 1107-1088 cm . Further, the existence of halogen group in compounds (6, 7, 9, 10, 13, 17 and 18) is indicated by the existence of ArCl stretching vibrations at 761-700 cm . The impression of IR stretching at 1692-1620 cm −1 in the spectra of specified the existence of NH-C=O group of synthesized derivatives. The multiplet signals between 6.74 and 9.08 δ, ppm in 1 H-NMR spectra is indicative of aromatic proton of synthesized derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . The compounds, 4, 19 and 20 showed singlet at 3.38-3.75 δ, ppm due to the presence of OCH 3 of Ar-OCH 3 in their structure. All compounds showed singlet at 7.47-7.91 δ, ppm due to the existence of N=CH in pyrimidine ring. Synthesized compounds showed appearance of IR stretching around 1349 cm −1 which indicated the presence of C-N sym str. of aromatic NO 2 group. Compounds, 5, 14 and 15 showed singlet at 2.09-2.51 δ, ppm due to existence of -CH 3 at ortho and para position. All compounds showed singlet at 3.34-3.38 δ, ppm and 8.00-8.08 δ, ppm due to the existence of -CH 2 -and -NH-groups respectively. The elemental analysis results of the synthesized bis-pyrimidine acetamide derivatives were found within ±0.4% of the theoretical results. Finally, the 13 C-NMR spectra of the bis-chalcone and the cyclized bis-pyrimidine were recorded in DMSO-d 6 and the spectral signals were in good agreement with the proposed molecular structure of the synthesized compounds. 13 C-NMR spectra details of all compounds are given in the experimental part. Characteristic molecular ion peaks were observed in the mass spectra of the bis-chalcone and the cyclized bis-pyrimidine and final bis-pyrimidine acetamide derivatives.
Antimicrobial activity
The synthesized compounds were screened for their in vitro antimicrobial activity by tube dilution method. 
found to be most effective ones against A. niger and C. albicans respectively. The rest of the compounds of the series exhibited average to poor antifungal activity. The antimicrobial activity results of synthesized bis-pyrimidine acetamide derivatives indicated that the synthesized compounds are more active than the standard drugs and may be taken as a lead compound to discover novel antimicrobial agents.
Anticancer activity
The anticancer screening (IC 50 = µmol/mL) of the synthesized bis-pyrimidine acetamide derivatives was The structure-activity relationship of the synthesized bis-pyrimidine acetamides indicated that the compounds bearing electron withdrawing group at different position of phenyl group plays an important role in enhancing the antimicrobial and anticancer potentials (Fig. 7) .
Experimental part
Preparatory materials for the research work were obtained from commercial sources and were used without further purification. All reactions were monitored by thin-layer chromatography on 0.25 mm silica gel (Merck) plates, using benzene as mobile phase and spots were observed by exposure to iodine vapours or visualized with UV light. Melting points of synthesized compounds was determined in open capillary tube. An infrared spectrum was recorded (KBr-pellets) in Bruker 12060280, Software: OPUS 7.2.139.1294 spectrometer. 
General procedure of the synthesized bis-pyrimidine acetamide derivatives (1-20)
Step
i: Synthesis of 3,3′-(1,4-phenylene)bis(1-(4-nitrophenyl)prop-2-en-1-one) (I)
A mixture of 1-(4-nitrophenyl) ethanone (0.02 mol) and terephthalaldehyde (0.01 mol) in methanol (5-10 mL) was stirred with drop wise addition of 40% sodium hydroxide solution (10 mL) at room temperature till a dark yellow mass was obtained (2-3 h). Then reaction mixture was allowed to stand overnight at room temperature and then was poured into icecold water and acidified with hydrochloric acid and the precipitated 3,3′-(1,4-phenylene)bis(1-(4-nitrophenyl) prop-2-en-1-one) was filtered, dried and recrystallized from methanol [23, 24] .
Step ii: Synthesis of 6,6′- (1,4- tate, 6,6′-(1,4-phenylene)bis(4-(4-nitrophenyl) pyrimidin-2-amine) was separated dried and recrystallized from methanol [23, 24] .
Step iii: Synthesis of N,N′-(6,6′-(1,4-phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis (2-chloroacetamide) (III) In ethanol (30 mL), chloroacetyl chloride (0.02 mol) and 2-3 drops of triethylamine were added and the mixture was stirred in water bath for 10 min after that the solution of 6,6′-(1,4-phenylene)bis(4-(4-nitrophenyl) pyrimidin-2-amine) (synthesized in previous step-ii) (0.01 mol) in ethanol (80 mL) was added drop wise and refluxed for 2-3 h. The reaction mixture was then cooled and poured into icecold water and resultant precipitate was filtered and washed with water, dried and recrystallized from alcohol [25] .
Step iv: Synthesis of final (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) bis-pyrimidine acetamide derivatives The reaction mixture of N,N′-(6,6′-(1,4-phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl)) bis(2-chloroacetamide) (0.01 mol) and substituted aniline (0.02 mol) in ethanol was refluxed for 4-5 h. The reaction progress was monitored by thin layer chromatography. After completion of reaction, the reaction mixture was poured into icecold water and the precipitated title compound was filtered, dried and recrystallized from methanol.
Spectral data interpretation of the synthesized compounds (Fig. 8) 
3,3′-(1,4-Phenylene)bis(1-(4-nitrophenyl)prop-2-en-1-one) (I) IR (KBr pellets, cm −1
): 3106 (C-H str., phenyl nucleus), 1517 (C=C str., phenyl nucleus), 1690 (C=O str.), 1598 (C=C str., alkyl chain), 2906 (C-H str., alkyl chain), 1341 (C-N sym str., Ar-NO 2 ); ): 3107 (C-H str., phenyl nucleus), 1518 (C=C str., phenyl nucleus), 3370 (C-NH 2 str.), 1600 (N=CH str., of pyrimidine), 1349 (C-N sym str., Ar-NO 2 ); 
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-chloroacetamide) (III) IR (KBr pellets, cm −1
): 3105 (C-H str., phenyl nucleus), 1519 (C=C str., phenyl nucleus), 1688 (NH-C=O str.), 1599 (N=CH str., of pyrimidine), 2928 (C-H str., CH 2 ), 761 (C-Cl str., Ar-Cl), 1349 (C-N sym. str., Ar-NO 2 ); ): 3084 (C-H str., phenyl nucleus), 1530 (C=C str., phenyl nucleus), 1687 (NH-C=O str.), 1603 (N=CH str., of pyrimidine), 2866 (C-H str., CH 2 ), 1215 (C-NH-str.), 1348 (C-N sym. str., Ar-NO 2 ), 739 (C-Cl str., Ar-Cl); ): 3108 (C-H str., phenyl nucleus), 1519 (C=C str., phenyl nucleus), 1665 (NH-C=O str.), 1600 (N=CH str., of pyrimidine), 2934 (C-H str., CH 2 ), 1211 (C-NH-str.), 1340 (C-N sym. str., Ar-NO 2 ), 1106 (C-F str., Ar-F); ): 3074 (C-H str., phenyl nucleus), 1520 (C=C str., phenyl nucleus), 1692 (NH-C=O str.), 1601 (N=CH str., of pyrimidine), 2853 (C-H str., CH 2 ), 1211 (C-NH-str.), 1343 (C-N sym. str., Ar-NO 2 ); ): 3074 (C-H str., phenyl nucleus), 1519 (C=C str., phenyl nucleus), 1664 (NH-C=O str.), 1597 (N=CH str., of pyrimidine), 2917 (C-H str., CH 2 ), 1208 (C-NH-str.), 1339 (C-N sym. str., Ar-NO 2 ); ): 3107 (C-H str., phenyl nucleus), 1519 (C=C str., phenyl nucleus), 1665 (NH-C=O str.), 1599 (N=CH str., of pyrimidine), 2933 (C-H str., CH 2 ), 1209 (C-NH-str.), 1341 (C-N sym. str., Ar-NO 2 ), 697 (C-Br str., Ar-Br); 
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((3-nitrophenyl) amino)acetamide) (1)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((4-nitrophenyl) amino)acetamide) (2)
Dark
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((2,4-dinitrophenyl) amino)acetamide) (3)
Brown
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((4-methoxyphenyl) amino)acetamide) (4)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-(p-tolylamino) acetamide) (5)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((4-chlorophenyl) amino)acetamide) (6)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((2-chloro-4-nitro phenyl)amino) acetamide) (7)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((2-nitrophenyl) amino)acetamide) (8)
Light
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-(2-chlorophenyl) acetamide) (9)
Canary
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((4-chloro-2-nitro phenyl)amino) acetamide) (13)
N,N′-(6,6′-(1,4-Phenylene)bis(4-(4-nitrophenyl)pyrimidine-6,2-diyl))bis(2-((2,3-dichlorophenyl) amino)aceta-
used in the experiments and DMSO had no effect on the microorganisms in the concentrations studied. The anticancer screening (IC 50 = µmol/mL) of synthesized compounds was determined against human colorectal carcinoma [HCT-116 (ATCC (American Type Culture Collection) CCL-247)] cancer cell line using sulforhodamine-B (SRB) assay. In this study, the culture material was fixed with trichloroacetic acid and then stained for 30 min with 0.4% (w/v) sulforhodamine B mixed with 1% acetic acid. Unbound dye was discarded by five washes of 1% acetic acid solution and protein-bound dye was extracted with 10 mM Tris base [tris(hydroxymethyl) aminomethane] for confirmation of optical density in a computer-interfaced, 96-well microtiter plate reader [28] .
Conclusion
In summary, a series of new bis-pyrimidine acetamide molecules was synthesized in good yields and its chemical structures were confirmed by 1 H/ 13 C-NMR, Mass, FT-IR studies and elemental analyses. All the synthesized compounds were tested for their in vitro antimicrobial and anticancer potentials. Among the synthesized compounds, compounds, 3, 13, 16, 17 and 18 exhibited good antimicrobial potential against different microorganism (bacterial species: S. aureus, B. subtilis, E. coli, P. aeruginosa, S. enterica and fungal species: A. niger and C. albicans) than the standard drugs cefadroxil and fluconazole. Similarly, compounds, 12, 16 and 18 were found to be more effective against HCT 116 cancer cell line than the standard drug, 5-fluorouracil.
